Valent Anticipates Registration for New Active Ingredient in its Seed Protectant AP3 Fungicide System
30 July 2012 Valent U.S.A. Corp. is anticipating registration of a new compound in its AP3 Fungicide System in 2013 offering growers, seed conditioners and seed companies across a number of crops a new tool in seed protection.
Ethaboxam, the key active ingredient in AP3 Fungicide System, which has been tested in a series of private and university research trials. Ethaboxam is a new compound that has been tested by researchers for several years.
“AP3 is consistently delivering exceptionally strong performance against the toughest early-season diseases,” said Karen Arthur, Valent Seed Protection Product Development Manager. “We continue to see extremely consistent and effective results from AP3 even in a variety of uncertain disease presence, pressure, resistance and springtime conditions. Plants protected by AP3 are appearing stronger and healthier while demonstrating greater stands in the spring for improved yield at harvest.”
The new seed protectant brings together multiple modes of action (MOAs), including ethaboxam, representing a new novel class of chemistry, to be used in combination with metalaxyl. Studies are showing AP3 is providing systemic and contact protection against oomycete pathogens such as Pythium, Phytophthora, downy mildew and Aphanomyces spp., including resistant and uncontrolled types.
Marty Robinson, Valent seed protection brand manager, said the anticipated registration of ethaboxam in 2013 will come at a critical time, as growers and seed professionals have been facing even greater resistance pressure in recent seasons, and AP3 field observations indicate continued broadening of the Pythium and Phytophthora spectrum.
Ethaboxam, the key active ingredient in AP3, is anticipated to be EPA registered on corn, soybeans, cereals, canola and sorghum crops. It is pending EPA registration, which is anticipated in 2013. It is not yet available for sale. The use of ethaboxam other than by qualified research personnel for research purposes is a violation of federal law.
Source: Valent, Edited by FCI Staff
Get The Newsletter Today!
